Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Examining the Effects of Dual and Single Task Exercises in Individuals with Type 2 Diabetes: A Randomized Controlled Trial.
Journal of clinical medicine·2026
Same author
Association between metabolic activity and molecular alterations in lung adenocarcinoma: Insights from 18F-FDG PET/CT.
Tuberkuloz ve toraks·2026
Same author
Structures at Risk With Intrapelvic Guide Wire Migration During Cephalomedullary Fixation of Hip Fractures: CT-Based Analysis.
Journal of orthopaedic trauma·2025
Peripheral neuropathy in chronic obstructive pulmonary disease.
Cağatay Oncel1, Sevin Baser, Mustafa Cam
1Pamukkale University, Denizli, Turkey. cagatayoncel@yahoo.com
COPD
|March 11, 2010
Summary
Chronic obstructive pulmonary disease (COPD) patients often experience subclinical peripheral nerve involvement, with neuropathy detected in 15% of cases. This study found no direct correlation between inflammation markers and nerve damage in COPD patients.
More Related Videos
Area of Science:
- Neurology
- Pulmonology
- Immunology
Background:
- Chronic obstructive pulmonary disease (COPD) is a systemic inflammatory condition.
- Peripheral nervous system (PNS) involvement is increasingly recognized in COPD.
- The relationship between inflammatory markers and PNS dysfunction in COPD requires further elucidation.
Purpose of the Study:
- To investigate the prevalence and characteristics of peripheral neuropathy in COPD patients.
- To explore the association between serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), insulin-like growth factor-1 (IGF-1), and C-reactive protein (CRP) with PNS involvement in COPD.
- To assess muscle strength and its correlation with electrophysiological findings and pulmonary function.
Main Methods:
- Nerve conduction studies (motor and sensory) were performed on 40 COPD patients and 33 healthy controls.
- Serum levels of TNF-alpha, IL-6, CRP, and IGF-1 were measured.
- Muscle strength was assessed using a hand-held dynamometer, and pulmonary function was evaluated by FEV(1)%.
Main Results:
- Peripheral neuropathy was identified in 15% of COPD patients.
- COPD patients showed significantly prolonged ulnar and sural nerve latencies, reduced peroneal nerve conduction velocities, and lower tibial nerve amplitudes compared to controls.
- Higher CRP and TNF-alpha, and lower IGF-1 levels were observed in COPD patients, but without correlation to electrophysiological findings. Reduced muscle strength was noted in COPD patients.
Conclusions:
- COPD patients exhibit subclinical peripheral nerve involvement, characterized by specific electrophysiological abnormalities.
- While inflammatory markers are altered in COPD, their direct correlation with peripheral nerve dysfunction was not established in this study.
- Reduced muscle strength and a positive correlation between left sural nerve sensory amplitude and FEV(1)% suggest a link between pulmonary function and peripheral nerve integrity.